一分钟看懂
这是一项关于卵巢癌的不适用研究，登记的药物或干预包括Ovarian Cancer Screening；Prophylactic Salpingectomy with Delayed Oophorectomy；Risk-Reducing Salpingo-Oophorectomy；Questionnaire；Transvaginal，当前状态为研究进行中，已停止招募。登记地点显示中国Evanston、Houston有研究中心记录。是否仍有名额以及是否值得进一步询问，需要向研究中心确认。
药物或干预
Ovarian Cancer Screening；Prophylactic Salpingectomy with Delayed Oophorectomy；Risk-Reducing Salpingo-Oophorectomy；Questionnaire；Transvaginal Ultrasound；Phone Call · 不适用
登记条件中文摘要
年龄范围：30岁至47岁
登记的基本范围为女性，年龄30岁至47岁；以下仅摘录8项专业入选条件，需结合英文原文并由研究团队确认。
登记记录列出8项主要排除条件，具体医学含义需结合英文原文并由研究团队确认。
中国哪些地方有记录
以下地点来自登记信息，不代表此刻仍有名额；请向研究中心确认最新情况。
- NorthShore University Health System · Evanston
- University of Texas MD Anderson Cancer Center · Houston
入选条件原文摘录
以下为摘录，请打开原始登记查看完整入排标准。
- 1. Premenopausal women with a documented BRCA1 or BRCA2 mutation. Menopause is defined as \>/= 12 months of amenorrhea.
- 2. Women must be at least 30 and less than 48 years of age.
- 3. Candidate for surgery and willing to undergo two surgical procedures (if chooses the PSDO arm).
- 4. Patient choosing PSDO or RRSO must desire permanent sterilization.
- 5. Presence of at least one fallopian tube. Prior tubal ligation is allowed.
- 6. Participants may have a personal history of non-ovarian malignancy, but must be without evidence of disease at enrollment and the patient must have completed treatment (including surgery, chemotherapy, or radiotherapy) \> 3 months prior to enrollment (other than non-melanoma skin cancer). Current or past SERM or aromatase inhibitor use is allowed.
- 7. Willingness to return to the enrolling site for any surgical procedures including pre-operative and post-operative care.
- 8. Willingness to return to the enrolling site for ovarian cancer screening during the study period.
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号：NCT01907789；登记信息更新于 2026-10-07；本站同步于 2026-10-08。